1. Home
  2. HALO vs RRC Comparison

HALO vs RRC Comparison

Compare HALO & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • RRC
  • Stock Information
  • Founded
  • HALO 1998
  • RRC 1976
  • Country
  • HALO United States
  • RRC United States
  • Employees
  • HALO N/A
  • RRC N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • RRC Oil & Gas Production
  • Sector
  • HALO Health Care
  • RRC Energy
  • Exchange
  • HALO Nasdaq
  • RRC Nasdaq
  • Market Cap
  • HALO 7.4B
  • RRC 8.0B
  • IPO Year
  • HALO N/A
  • RRC N/A
  • Fundamental
  • Price
  • HALO $52.02
  • RRC $40.09
  • Analyst Decision
  • HALO Buy
  • RRC Hold
  • Analyst Count
  • HALO 9
  • RRC 18
  • Target Price
  • HALO $63.56
  • RRC $42.41
  • AVG Volume (30 Days)
  • HALO 3.1M
  • RRC 3.0M
  • Earning Date
  • HALO 05-06-2025
  • RRC 04-22-2025
  • Dividend Yield
  • HALO N/A
  • RRC 0.89%
  • EPS Growth
  • HALO 55.40
  • RRC N/A
  • EPS
  • HALO 3.76
  • RRC 1.11
  • Revenue
  • HALO $1,084,306,000.00
  • RRC $2,610,836,000.00
  • Revenue This Year
  • HALO $24.79
  • RRC $29.81
  • Revenue Next Year
  • HALO $22.65
  • RRC $11.52
  • P/E Ratio
  • HALO $13.83
  • RRC $36.14
  • Revenue Growth
  • HALO 25.64
  • RRC 12.00
  • 52 Week Low
  • HALO $41.28
  • RRC $27.29
  • 52 Week High
  • HALO $70.51
  • RRC $41.95
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • RRC 67.28
  • Support Level
  • HALO $47.50
  • RRC $39.64
  • Resistance Level
  • HALO $69.94
  • RRC $40.99
  • Average True Range (ATR)
  • HALO 3.52
  • RRC 0.97
  • MACD
  • HALO -1.49
  • RRC 0.71
  • Stochastic Oscillator
  • HALO 19.64
  • RRC 88.11

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About RRC Range Resources Corporation

Fort Worth-based Range Resources is an independent exploration and production company with that focuses entirely on its operations in the Marcellus Shale in Pennsylvania. At year-end 2024, Range Resources' proven reserves totaled 18.1 trillion cubic feet equivalent, with net production of 2.18 billion cubic feet equivalent per day. Natural gas accounted for 68% of production.

Share on Social Networks: